The FSBI RCMG team - participants of the international symposium on cystic fibrosis issues
On February 6, 2019, the International Symposium "Neonatal screening for cystic fibrosis in Europe and the United States: today, tomorrow and in the future" was held in Brest (France).
The focus areas of the research program were the historical arrangement of neonatal screening for cystic fibrosis in Europe and the United States. They discussed difficulties of confirming the diagnosis identified by neonatal screening in some patients, the ethical aspects of an “uncertain diagnosis”. They emphasized prescribing CFTR modulators to the newborn with a caution, the relationship of early detection of cystic fibrosis with the course of disease in adulthood and its effect on the prognosis in general in such countries as France, UK, Italy, Russia and the USA.
Prof. Kashirskaya N.Yu., Doctor of medical science, Chief researcher at the FSBI RCMG Genetic Epidemiology Laboratory, (headed by Prof. Zinchenko R.A.) made an an oral presentation prepared jointly with the team of the Cystic Fibrosis Research and Counselling Department, Professor Kondratieva E.I., Doctor of medical science, and Sherman V.D., Candidate of medical science (Head is Kondratieva E.I., Dr. of med.sc.): “The current status of newborn screening in Russia: how to manage in a very large country from the Baltic Sea to the Bering Strait". The Symposium participants expressed great interest in the presentation.